EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall St futures gain as pause in US-Iran hostilities lifts sentiment
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices hit one-week low after US, Iran pause fighting over weekend
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
- Oil prices hit one-week low after US, Iran pause fighting over weekend
- Suspect in Berlin Pride attack shot dead by police
Edwards Lifesciences (EW) Misses Q4 EPS by 4c, Offers Guidance
January 26, 2022 4:17 PM ESTEdwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.51, $0.04 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.36 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2022 EPS of $0.54-$0.62, versus the consensus of $0.60.... More
